IBI-30089
N/A
Report date: 2025/01/26 18:28:48
NME
Base Information
Drug NameIBI-30089
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIcon Bioscience Inc
China Registration ClassN/A
Develop Information
Active CompaniesEyepoint Pharmaceuticals Inc
Inactive CompaniesIcon Bioscience Inc
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A